TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$679M
AUM Growth
+$69.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$58.1M
2
+$37.8M
3
+$35.1M
4
INBX
Inhibrx, Inc. Common Stock
INBX
+$32.1M
5
CMPS
Compass Pathways
CMPS
+$28.5M

Top Sells

1
+$96.3M
2
+$52.9M
3
+$12.3M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$5.49M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$2.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$75.8M 11.16%
1,502,747
+1,152,747
2
$54.9M 8.08%
5,631,042
3
$49.6M 7.3%
23,375,839
-213,940
4
$43.1M 6.34%
2,678,209
+1,388,889
5
$37.8M 5.57%
+10,000,000
6
$35.1M 5.17%
+11,111,111
7
$32.7M 4.81%
3,395,495
8
$32.1M 4.73%
+1,750,387
9
$29.9M 4.4%
62,894
10
$28.7M 4.23%
3,703,704
11
$28.5M 4.2%
+3,858,000
12
$28.3M 4.17%
815,724
13
$27.4M 4.03%
1,989,103
14
$26.3M 3.87%
179,917
+30,000
15
$20.7M 3.04%
2,104,875
16
$20.3M 2.99%
+1,142,857
17
$19.3M 2.84%
+869,908
18
$14.8M 2.18%
1,650,150
19
$13.2M 1.94%
+2,040,816
20
$13M 1.91%
1,423,642
21
$12.9M 1.89%
334,853
-320,000
22
$9.24M 1.36%
584,955
23
$8.75M 1.29%
+3,038,889
24
$7.41M 1.09%
486,795
25
$7.07M 1.04%
300,000
1
2